ENDRA Life Sciences (NASDAQ: NDRAU) is engaged in the development of photo- and thermo-acoustic medical technologies that bring new capabilities to existing ultrasound systems, helping global medical researchers screen and modify disease models with high image quality and volume scanning speed. ENDRA’s global installed base consists of leading institutions that use the Nexus-128 system, which is the only commercially available 3D imaging system for imaging anatomy, physiology and labeled molecular targets. The company’s thermo-acoustic technology is being developed to enable clinicians to use existing ultrasound equipment to visualize tissue function and composition and to monitor various therapeutic interventions at the point of care. For more information, visit the company’s website at www.endrainc.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3) a full array of social communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
